# OnCo record nct01890746 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct01890746/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct01890746", "NCT01890746" ;
  schema:name "A Safety and Efficacy Study of Eltrombopag in Subjects With AML"@en ;
  schema:description "A phase 2 trial of Daunorubicin, Cytarabine and Eltrombopag in Leukaemia, run by Novartis Pharmaceuticals, completed."@en ;
  schema:url <https://onco.cc/trials/nct01890746/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01890746> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/leukaemia/> ;
  onco:drugs <https://onco.cc/drugs/daunorubicin/>, <https://onco.cc/drugs/cytarabine/>, <https://onco.cc/drugs/eltrombopag/> .